China
Africa
Explore chapters and articles related to this topic
Temporal Region and Lateral Brow
Published in Ali Pirayesh, Dario Bertossi, Izolda Heydenrych, Aesthetic Facial Anatomy Essentials for Injections, 2020
Krishan Mohan Kapoor, Alberto Marchetti, Hervé Raspaldo, Shino Bay Aguilera, Natalia Manturova, Dario Bertossi
The MTV runs approximately 1 cm above and parallel to the zygomatic arch, buried in the superficial temporal fat pad, and travels between the superficial and deep layers of the deep temporal fascia. It (Figure 2.17): Is an important blood vessel in the temporal fossa.Drains blood from the temporal muscle and deep aspect of the temporal fossa.Receives a communicating vessel from the supraorbital vein.Travels between the two layers of deep temporal fascia.Joins the superficial temporal vein just at or below the level of the zygomatic arch.
The Gallbladder (GB)
Published in Narda G. Robinson, Interactive Medical Acupuncture Anatomy, 2016
Supraorbital vein: Begins by anastomosing with a tributary of the superficial temporal vein, joins the supratrochlear and superior ophthalmic veins, and ends as the angular vein, at the root of the nose. It drains the forehead and anterior part of the scalp.
Acute unilateral vision loss and bilateral cerebral infarction following cosmetic filler injection
Published in Orbit, 2023
Huda AlGhadeer, Mohammed Talea, Ahmed Al-Muhaylib, Osama AlSheikh, Sahar M. Elkhamary
In the current patient, it appears that an intravenous injection in the supraorbital vein must have gone retrograde into the cavernous sinus. She developed symptoms related to the findings of cavernous sinus involvement, with headache and impairment of the cranial nerves near the cavernous sinus resulting in the ophthalmoplegia. The patient demonstrated a severe ophthalmological presentation with ptosis, combined with unilateral blindness after arterial occlusion. Headache and ocular pain after the injection could be warning signs of the complications described in the current report. Hence, it is suggested that the physicians should be alert and halt further injections immediately to minimize the damage if such complications arise. Several measures can minimize the risk of vascular complications. They include a thorough understanding of facial anatomy, aspiration before each injection, and low-pressure injections of minimal volumes (<0.1 ml/injection). Improvement of the visual acuity in the patients with vascular occlusions after filler injection is extremely rare, and there are no reports of complete visual recovery after the initial injury.13 In the current case, vision loss was permanent but periocular symptoms such as ptosis and other ophthalmic manifestations were resolved completely. The present case should serve as a caution and example that simple procedures could cause devastating damage.